(HealthDay)—A phase I trial of dasatinib combined with paclitaxel and carboplatin has determined the optimal dose of dasatinib and suggested some efficacy in women with advanced or recurrent ovarian cancer, according to ...
Nov 19, 2012
0
0
(HealthDay) -- The combination of temozolomide and bevacizumab seems to benefit patients with advanced pancreatic neuroendocrine tumors (NETs), according to a study published online July 9 in the Journal of Clinical Oncology.
Jul 13, 2012
0
0
(HealthDay) -- More than half of patients with relapsed or refractory systemic anaplastic large-cell lymphoma (ALCL) treated with the CD30-directed antibody-drug conjugate brentuximab vedotin achieve a complete remission, ...
May 24, 2012
0
0
(HealthDay) -- For patients with relapsed or refractory multiple myeloma, combination treatment with elotuzumab, lenalidomide, and low-dose dexamethasone is generally well tolerated, with encouraging response rates, according ...
May 2, 2012
0
0
Researchers at St. Michael's Hospital have identified a potential new cause for unexplained miscarriages in mice.
Nov 1, 2011
0
0
Patients who had undergone hemodialysis using dialyzers that had been sterilized with the use of electron beams were more likely to develop thrombocytopenia (an abnormally low platelet count in the blood, associated with ...
Oct 18, 2011
0
0
Researchers from Boston University School of Medicine (BUSM) have found that computed tomography pulmonary angiography (CTPA), meant to improve detection of life-threatening pulmonary embolisms (PE), has led to over-diagnosis ...
May 9, 2011
0
0
In a novel approach that works around the gene defect in Wiskott-Aldrich syndrome, an inherited immune deficiency disorder, researchers used an alternative cell signaling pathway to significantly improve immune function in ...
Apr 14, 2011
0
0
Testing for rare heparin reaction is unnecessary for most cases and can be potentially harmful and lead to increased costs, according to an article published in JAMA Internal Medicine.
Apr 28, 2016
0
3
Fetal and neonatal immune thrombocytopenia (FNIT; aka FNAIT) is a condition in which fetuses and newborns have reduced numbers of blood cells known as platelets.
Oct 24, 2011
1
0
